Skip to main content

Pfizer's drug for advanced lung cancer shows promising long-term trial results

The company's medicine helped patients live longer without seeing their cancer progress, as most of them experienced that benefit for over five years.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.